The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2018
Filed:
Nov. 13, 2014
The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Washington, DC (US);
Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);
Queen Mary University of London, London, GB;
Board of Regents of the University of Nebraska, Lincoln, NE (US);
Oslo University Hospital Hf, Oslo, NO;
Oregon Health & Science University, Portland, OR (US);
University of Rochester, Rochester, NY (US);
Hospital Clinic DE Barcelona, Barcelona, ES;
Universitat DE Barcelona, Barcelona, ES;
British Columbia Cancer Agency Branch, Vancouver, CA;
Julius-maximilians-university of Wuerzburg, Wuerzburg, DE;
Lisa Rimsza, Tucson, AZ (US);
Andrew T. Lister, London, GB;
Wing C. Chan, Omaha, NE (US);
Dennis Weisenburger, Elkhorn, NE (US);
Jan Delabie, Oslo, NO;
Erlend B. Smeland, Oslo, NO;
Harald Holte, Oslo, NO;
Stein Kvaloy, Oslo, NO;
Rita M. Braziel, West Linn, OR (US);
Richard I. Fisher, Pittsford, NY (US);
Pedro Jares, Barcelona, ES;
Armando Lopez-Guillermo, Barcelona, ES;
Elias Campo Guerri, Barcelona, ES;
Elaine S. Jaffe, Great Falls, VA (US);
Georg Lenz, Berlin, DE;
Wyndham H. Wilson, Washington, DC (US);
George Wright, Rockville, MD (US);
Sandeep S. Dave, Chapel Hill, NC (US);
Louis M. Staudt, Bethesda, MD (US);
Randy D. Gascoyne, North Vancouver, CA;
Joseph M. Connors, Vancouver, CA;
Hans-Konrad Muller-Hermelink, Wrzburg, DE;
Andreas Rosenwald, Wuerzburg, DE;
German Ott, Bietigheim-Bissingen, DE;
The United States of America, as represented by the Secretary, Department of Human Services, Washington, DC (US);
Arizona Board of Regents on behalf of the University of Arizona, Tucson, AZ (US);
Queen Mary University of London, London, GB;
Board of Regents of the University of Nebraska, Lincoln, NE (US);
Oslo University Hospital HF, Oslo, NO;
Oregon Health & Science University, Portland, OR (US);
University of Rochester, Rochester, NY (US);
Hospital Clinic de Barcelona, Barcelona, ES;
Universitat de Barcelona, Barcelona, ES;
British Columbia Cancer Agency Branch, Vancouver, CA;
Julius-Maximilians-University of Würzburg, Würzburg, DE;
Abstract
The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.